NPPB and cardiac hypertrophy: 3,4,5,4′-TMS administration was found to reduce cardiac hypertrophy and cardiac fibrosis, which was characterized by the decrease in the brain natriuretic peptide (BNP), α-smooth muscle actin-positive cells and macrophages in the myocardium [76,77].